140 related articles for article (PubMed ID: 24574829)
1. Risks associated with sunitinib use and monitoring to improve patient outcomes.
Choi BS
Korean J Intern Med; 2014 Jan; 29(1):23-6. PubMed ID: 24574829
[No Abstract] [Full Text] [Related]
2. Renal adverse effects of sunitinib and its clinical significance: a single-center experience in Korea.
Baek SH; Kim H; Lee J; Kim DK; Oh KH; Kim YS; Han JS; Kim TM; Lee SH; Joo KW
Korean J Intern Med; 2014 Jan; 29(1):40-8. PubMed ID: 24574832
[TBL] [Abstract][Full Text] [Related]
3. Sunitinib-induced thrombotic microangiopathy.
Noronha V; Punatar S; Joshi A; Desphande RV; Prabhash K
J Cancer Res Ther; 2016; 12(1):6-11. PubMed ID: 27072203
[TBL] [Abstract][Full Text] [Related]
4. A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib.
Patel TV; Morgan JA; Demetri GD; George S; Maki RG; Quigley M; Humphreys BD
J Natl Cancer Inst; 2008 Feb; 100(4):282-4. PubMed ID: 18270341
[No Abstract] [Full Text] [Related]
5. Allergic interstitial nephritis possibly related to sunitinib use.
Khurana A
Am J Geriatr Pharmacother; 2007 Dec; 5(4):341-4. PubMed ID: 18179992
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of sunitinib in hemodialysis.
Izzedine H; Etienne-Grimaldi MC; Renée N; Vignot S; Milano G
Ann Oncol; 2009 Jan; 20(1):190-2. PubMed ID: 18801884
[No Abstract] [Full Text] [Related]
7. Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer.
Kalantari HR
Br J Cancer; 2009 Oct; 101(7):1222-3; author reply 1224. PubMed ID: 19755985
[No Abstract] [Full Text] [Related]
8. "Pseudocavitation" in thymic carcinoma during treatment with sunitinib.
Tiseo M; Rajan A; Thomas A; Giaccone G
J Thorac Oncol; 2013 Apr; 8(4):511-2. PubMed ID: 23486269
[No Abstract] [Full Text] [Related]
9. Sunitinib-induced thyrotoxicosis.
Piñar D; Boix E; Meana JA; Herrero J
J Endocrinol Invest; 2009 Dec; 32(11):941-2. PubMed ID: 19636224
[No Abstract] [Full Text] [Related]
10. Erosive nappy erythema following sunitinib intake.
Kharmoum S; Errihani H
Pan Afr Med J; 2013; 14():46. PubMed ID: 23560129
[No Abstract] [Full Text] [Related]
11. Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma.
Flaig TW; Kim FJ; La Rosa FG; Breaker K; Schoen J; Russ PD
Invest New Drugs; 2009 Feb; 27(1):83-7. PubMed ID: 18563296
[No Abstract] [Full Text] [Related]
12. Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency.
Kim KH; Kim HY; Kim HR; Sun JM; Lim HY; Lee HJ; Lee S; Bae WK; Rha SY; ;
Eur J Cancer; 2014 Mar; 50(4):746-52. PubMed ID: 24332573
[TBL] [Abstract][Full Text] [Related]
13. Sunitinib-induced nephrotic syndrome and irreversible renal dysfunction.
Takahashi D; Nagahama K; Tsuura Y; Tanaka H; Tamura T
Clin Exp Nephrol; 2012 Apr; 16(2):310-5. PubMed ID: 21964704
[TBL] [Abstract][Full Text] [Related]
14. Myelosuppression by sunitinib is flt-3 genotype dependent.
van Erp NP; Mathijssen RH; van der Veldt AA; Haanen JB; Reyners AK; Eechoute K; Boven E; Wessels JA; Guchelaar HJ; Gelderblom H
Br J Cancer; 2010 Aug; 103(5):757-8. PubMed ID: 20683446
[No Abstract] [Full Text] [Related]
15. Reversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy.
van der Veldt AA; van den Eertwegh AJ; Hoekman K; Barkhof F; Boven E
Ann Oncol; 2007 Oct; 18(10):1747-50. PubMed ID: 17890217
[No Abstract] [Full Text] [Related]
16. Treatment of hemodialyzed patient with sunitinib.
Reckova M; Kakalejcik M; Beniak J
Ann Oncol; 2009 Feb; 20(2):392-3. PubMed ID: 19136449
[No Abstract] [Full Text] [Related]
17. Tolerance of sunitinib in dialyzed patients with metastatic renal cell carcinoma.
Vickers MM; Heng DY; Hemmelgarn B; Eigl BJ
Clin Genitourin Cancer; 2009 Oct; 7(3):E104-6. PubMed ID: 19815480
[TBL] [Abstract][Full Text] [Related]
18. Neurosensory retinal detachment due to sunitinib treatment.
Wegner A; Khoramnia R
Eye (Lond); 2011 Nov; 25(11):1517-8. PubMed ID: 21852804
[No Abstract] [Full Text] [Related]
19. Sporadic CNS hemangioblastomatosis, response to sunitinib and secondary polycythemia.
Reyes-Botero G; Gállego Pérez-Larraya J; Sanson M
J Neurooncol; 2012 Apr; 107(2):439-40. PubMed ID: 22076450
[No Abstract] [Full Text] [Related]
20. Exfoliative esophagitis in a patient with metastatic renal cell carcinoma during sunitinib treatment.
Huang J; Wang T; Huang Y
Med Oncol; 2013 Mar; 30(1):436. PubMed ID: 23283650
[No Abstract] [Full Text] [Related]
[Next] [New Search]